Form D · Biotechnology
Aldeyra Therapeutics, Inc.
Lexington, MA · CIK 0001341235
Offering snapshot reported Feb 11, 2019 · SEC filing
- Reported sold
- $10M Offering amount: $25M
- Investors reported
- 37 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 28, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2019 | Initial | $10,000,000 | No comparison | 37 | SEC filing |
| Feb 5, 2015 | Initial | $1,999,997 | No comparison | 1 | SEC filing |
| Jan 29, 2015 | Initial | $7,791,560 | No comparison | 16 | SEC filing |
| Jan 3, 2013 | Initial | $4,793,666 | No comparison | 2 | SEC filing |
| Aug 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 6, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-332606
13(a) includes the consideration issuable upon the achievement of certain milestones in connection with the transaction. 13(b) represents 1,150,990 shares of common stock issued to the former securityholders and an advisor of Helio.
Source: Form D, filed Feb 11, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Brady | Director, Executive |
| Ben Bronstein | Director |
| Gerald Cagle | Director, Executive |
| David L. Clark | Executive |
| C. Boyd Clarke | Director |
| C.Boyd Clarke | Director |
| Richard Douglas | Director |
| John Dowling | Director |
| Martin J. Joyce | Director |
| Stephen Machatha | Executive |
| David Mc Mullin | Executive |
| Gary Phillips | Director |
| Joshua Reed | Executive |
| Jesse I. Treu | Director |
| Stephen Tulipano | Executive |
| Neal Walker | Director |
| Asish Xavier | Director |
| Scott Young | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
131 Hartwell Avenue Suite 320
Lexington, MA, 02421
Lexington, MA, 02421